Skip to Main Content (Press Enter)

Logo CNR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNI-FIND
Logo CNR

|

UNI-FIND

cnr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms

Academic Article
Publication Date:
2013
abstract:
Context: Diabetes remission is frequent after biliopancreatic diversion (BPD) in morbidly obese
patients with type 2 diabetes (T2D). Data, mechanisms, and clinical indications in nonobese T2D
patients are scanty.
Objective: The objective of the study was to assess remission and investigate insulin sensitivity and
-cell function after BPD in nonobese patients with long-standing T2D.
Design, Setting, and Patients: This was a clinical research study comparing 15 T2D patients (aged
55 1 years, duration of 16 2 years, body mass index of 28.3 0.6 kg/m2, glycosylated hemoglobin
8.6% 1.3%) with 15 gender-, age-, and body mass index-matched nondiabetic controls.
Before surgery and 2 months and 1 year later, a 3-hour oral glucose tolerance test, a 5-hour
mixed-meal test, and a 3-hour euglycemic clamp were performed.
Intervention: The intervention included a BPD (distal gastrectomy, proximal ileum anastomosed to
remaining stomach, biliopancreatic limb anastomosed to ileum 50 cm from the ileocecal valve).
Results: Glycemia improved in all patients, but remission (glycosylated hemoglobin 6.5% and
normal oral glucose tolerance test) occurred in 6 of 15 patients. Insulin resistance (19.8 0.8
mol min1 kgffm
1, P .001 vs 40.9 5.3 of controls) resolved already at 2 months (34.2
2.8) and was sustained at 1 year (34.7 1.6), although insulin-mediated suppression of endogenous
glucose production remained impaired. In contrast, -cell glucose sensitivity (19 [12]
pmolmin1 m2mM1 vs 96 [73] of controls, P .0001) rose (P .02) only to 31 [26] at 1 year
and was lower in nonremitters (16 [18]) than remitters (46 [33]).
Conclusions: In nonobese patients with long-standing T2D, BPD improves metabolic control but
induces remission in only approximately 40% of patients. Peripheral insulin sensitivity is restored
early after surgery and similarly in remitters and nonremitters, indicating a weight-independent
effect of the operation. The initial extent of -cell incompetence is the main predictor of the
metabolic outcome
Iris type:
01.01 Articolo in rivista
List of contributors:
Gastaldelli, Amalia; Mari, Andrea
Authors of the University:
GASTALDELLI AMALIA
Handle:
https://iris.cnr.it/handle/20.500.14243/206294
Published in:
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Journal
  • Overview

Overview

URL

http://www.ncbi.nlm.nih.gov/pubmed/23666972
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.1.0 | Sorgente dati: PREPROD (Ribaltamento disabilitato)